Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1999Journal of Clinical InvestigationOpen Access

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

View Full Paper
Ask AI
Bookmark
Share

Authors

SKShigeru KotakeNational Institutes of HealthNUNobuyuki UdagawaMatsumoto Dental UniversityNTNaoyuki TakahashiShowa University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kotake et al. (1999) studied this question.

synapsesocial.com/papers/6a15a8e19b87f33fc69fbda3https://doi.org/10.1172/jci5703
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor1997 · 869 citations
  2. 2TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells1997 · 1,061 citations
  3. 3Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor1998 · 203 citations
  4. 4Human IL-17: a novel cytokine derived from T cells1995 · 1,033 citations
  5. 5Mouse IL-17: A Cytokine Preferentially Expressed by αβTCR+CD4—CD8— T Cells1996 · 137 citations